BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$14.25
−0.80%Leverage
- Debt / equity
- 1.16x
- Net debt / equity
- 1.03x
- Debt / assets
- 0.39x
- Debt / EBITDA
- 2.84x
- Net debt / EBITDA
- 2.52x
Liquidity & coverage
- Current ratio
- 1.69x
- Quick ratio
- 1.17x
- Cash ratio
- 0.19x
- Interest coverage
- 3.11x
- EBITDA / interest
- 4.67x
- Working capital
- $105.1M
Cash & dividend
- FCF / debt
- 0.36x
- Cash flow / debt
- 0.37x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026